262 related articles for article (PubMed ID: 31014988)
1. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
2. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.
Robertson JM; Lawrence TS; Dworzanin LM; Andrews JC; Walker S; Kessler ML; DuRoss DJ; Ensminger WD
J Clin Oncol; 1993 Jul; 11(7):1286-93. PubMed ID: 8391066
[TBL] [Abstract][Full Text] [Related]
3. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
[TBL] [Abstract][Full Text] [Related]
4. Mortality from hepatocellular and biliary cancers: changing epidemiological trends.
Nair S; Shiv Kumar K; Thuluvath PJ
Am J Gastroenterol; 2002 Jan; 97(1):167-71. PubMed ID: 11808943
[TBL] [Abstract][Full Text] [Related]
5. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
[TBL] [Abstract][Full Text] [Related]
6. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
[TBL] [Abstract][Full Text] [Related]
7. Surgical Treatments of Hepatobiliary Cancers.
Gunasekaran G; Bekki Y; Lourdusamy V; Schwartz M
Hepatology; 2021 Jan; 73 Suppl 1():128-136. PubMed ID: 32438491
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.
Pulte D; Weberpals J; Schröder CC; Emrich K; Holleczek B; Katalinic A; Luttmann S; Sirri E; Jansen L; Brenner H;
Int J Cancer; 2018 Jul; 143(2):324-332. PubMed ID: 29479701
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Carcinoma in a Tertiary Referral Hospital in Indonesia: Lack of Improvement of One-Year Survival Rates between 1998-1999 and 2013-2014.
Loho IM; Hasan I; Lesmana CR; Dewiasty E; Gani RA
Asian Pac J Cancer Prev; 2016; 17(4):2165-70. PubMed ID: 27221913
[TBL] [Abstract][Full Text] [Related]
10. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
11. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.
Cance WG; Stewart AK; Menck HR
Cancer; 2000 Feb; 88(4):912-20. PubMed ID: 10679662
[TBL] [Abstract][Full Text] [Related]
12. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
14. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review.
Glantzounis GK; Tokidis E; Basourakos SP; Ntzani EE; Lianos GD; Pentheroudakis G
Eur J Surg Oncol; 2017 Jan; 43(1):32-41. PubMed ID: 27283892
[TBL] [Abstract][Full Text] [Related]
15. Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy.
Sofue K; Arai Y; Shimada K; Takeuchi Y; Kobayashi T; Satake M; Sugimura K
Br J Surg; 2014 Aug; 101(9):1122-8. PubMed ID: 24920297
[TBL] [Abstract][Full Text] [Related]
16. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.
von Hahn T; Ciesek S; Wegener G; Plentz RR; Weismüller TJ; Wedemeyer H; Manns MP; Greten TF; Malek NP
Scand J Gastroenterol; 2011 Sep; 46(9):1092-8. PubMed ID: 21692710
[TBL] [Abstract][Full Text] [Related]
18. Advances in Targeted Immunotherapy for Hepatobiliary Cancers.
Ruff SM; Shannon AH; Pawlik TM
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430440
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.
Castro FA; Liu X; Försti A; Ji J; Sundquist J; Sundquist K; Koshiol J; Hemminki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1038-45.e7. PubMed ID: 24246767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
